Organon (OGN) Times Interest Earned (2021 - 2026)

Organon (OGN) posted quarterly Times Interest Earned of $2.12 for Q1 2026, up 9.84% year-over-year from $1.93 in Q1 2025, and up 21.99% on a QoQ basis from $1.74 in Q4 2025.

Organon (OGN) Times Interest Earned (2021 - 2026) Analysis & Trends

Organon (OGN) has reported Times Interest Earned for 6 consecutive years, with $2.12 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Times Interest Earned rose 9.84% year-over-year to $2.12; the TTM figure through Mar 2026 stood at $2.3 (down 11.07% YoY), while the FY2025 annual figure was $2.24, up 590.48% from the prior year.
  • Times Interest Earned came in at $2.12 for Q1 2026 at Organon, up from $1.74 in the prior quarter.
  • The five-year high for Times Interest Earned was $3.26 in Q3 2024, with the low at -$4.49 in Q4 2023.
  • Average Times Interest Earned over 5 years is -$0.51, with a median of -$1.23 recorded in 2022.
  • Across the five-year window, Times Interest Earned plunged 113.04% in 2023 and soared 200.76% in 2024, its largest moves.
  • Year by year, Times Interest Earned stood at -$4.06 in 2022, then fell by 10.58% to -$4.49 in 2023, then soared by 148.61% to $2.18 in 2024, then retreated by 20.45% to $1.74 in 2025, then gained by 21.99% to $2.12 in 2026.
  • According to Business Quant data, Times Interest Earned over the past three periods registered $2.12, $1.74, and $2.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 23.39
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -10.80
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 4.06
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 10.78
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 2.12

Historic Data

Download Data
DateValue
Mar 31, 2026 2.12
Dec 31, 2025 1.74
Sep 30, 2025 2.80
Jun 30, 2025 2.47
Mar 31, 2025 1.93
Dec 31, 2024 2.18
Sep 30, 2024 3.26
Jun 30, 2024 2.95
Mar 31, 2024 -3.27
Dec 31, 2023 -4.49
Sep 30, 2023 -3.97
Jun 30, 2023 -2.92
Mar 31, 2023 -2.61
Dec 31, 2022 -4.06
Sep 30, 2022 -2.49
Jun 30, 2022 -3.07
Mar 31, 2022 -1.23
Dec 31, 2021 -3.70
Sep 30, 2021 -2.24
Jun 30, 2021 -2.35